Los hipertensos son más susceptibles a los daños que causa un fármaco contra el cáncer
Investigadores del Centro Nacional de Investigaciones Cardiovasculares confirmaron que los pacientes con hipertensión arterial tienen un riesgo significativamente mayor de sufrir daño cardíaco al recibir antraciclinas, uno de los tratamientos contra el cáncer más utilizados, según un estudio publicado en European Heart Journal
TL;DR
- Anthracycline chemotherapy, used for decades to treat various cancers, can cause cardiotoxicity.
- The risk of anthracycline-induced cardiac damage is significantly higher in patients with arterial hypertension.
- An experimental model showed that pre-existing high blood pressure combined with anthracyclines led to severe heart damage and increased mortality.
- Researchers identified a potential preventive strategy that, if confirmed in clinical studies, could mitigate this risk in hypertensive patients.
- This anticipatory medicine approach aims to identify vulnerability before clinical damage occurs.